- Home
- PLUR vs QCLS Comparison
PLUR vs QCLS Comparison
Compare PLUR & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLUR | QCLS |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | Israel | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9M | 27.6M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLUR | QCLS |
|---|---|---|
| Price | $3.35 | $3.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 350.6K |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,336,000.00 | N/A |
| Revenue This Year | $97.38 | N/A |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 309.82 | N/A |
| 52 Week Low | $2.82 | $2.50 |
| 52 Week High | $6.10 | $8.17 |
Technical Indicators
Market Signals| Indicator | PLUR | QCLS |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 53.77 |
| Support Level | $3.12 | $3.38 |
| Resistance Level | $3.42 | $3.86 |
| Average True Range (ATR) | 0.14 | 0.30 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 21.64 | 57.53 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About QCLS Q/C Technologies Inc.
Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.